Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7805774rdf:typepubmed:Citationlld:pubmed
pubmed-article:7805774lifeskim:mentionsumls-concept:C0034826lld:lifeskim
pubmed-article:7805774lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:7805774lifeskim:mentionsumls-concept:C1979963lld:lifeskim
pubmed-article:7805774lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:7805774lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:7805774lifeskim:mentionsumls-concept:C0249301lld:lifeskim
pubmed-article:7805774pubmed:issue3lld:pubmed
pubmed-article:7805774pubmed:dateCreated1995-1-30lld:pubmed
pubmed-article:7805774pubmed:abstractTextThe binding selectivity of the muscarinic antagonist tripitramine has been tested on the five cloned human muscarinic receptor subtypes (Hm1 to Hm5) expressed in chinese hamster ovary (CHO-K1) cells. The results indicate that tripitramine binds to the muscarinic Hm2 receptor with a Ki value of 0.27 +/- 0.02 nM. Tripitramine distinguishes Hm2 vs. Hm4 by a factor of 24 and vs. Hm3 and Hm5 by a factor of 142 and 125, respectively. A lower affinity ratio, about 6-fold, was found between muscarinic Hm2 and Hm1 receptors. A comparative study with the well-known selective muscarinic M2 receptor antagonist methoctramine indicates that tripitramine has gained both potency and selectivity for the muscarinic Hm2 receptor subtype.lld:pubmed
pubmed-article:7805774pubmed:languageenglld:pubmed
pubmed-article:7805774pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7805774pubmed:citationSubsetIMlld:pubmed
pubmed-article:7805774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7805774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7805774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7805774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7805774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7805774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7805774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7805774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7805774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7805774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7805774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7805774pubmed:statusMEDLINElld:pubmed
pubmed-article:7805774pubmed:monthAuglld:pubmed
pubmed-article:7805774pubmed:issn0014-2999lld:pubmed
pubmed-article:7805774pubmed:authorpubmed-author:BarbierPPlld:pubmed
pubmed-article:7805774pubmed:authorpubmed-author:MelchiorreCClld:pubmed
pubmed-article:7805774pubmed:authorpubmed-author:MinariniAAlld:pubmed
pubmed-article:7805774pubmed:authorpubmed-author:TedeschiDDlld:pubmed
pubmed-article:7805774pubmed:authorpubmed-author:MaggioRRlld:pubmed
pubmed-article:7805774pubmed:authorpubmed-author:BolognesiM...lld:pubmed
pubmed-article:7805774pubmed:issnTypePrintlld:pubmed
pubmed-article:7805774pubmed:day16lld:pubmed
pubmed-article:7805774pubmed:volume268lld:pubmed
pubmed-article:7805774pubmed:ownerNLMlld:pubmed
pubmed-article:7805774pubmed:authorsCompleteYlld:pubmed
pubmed-article:7805774pubmed:pagination459-62lld:pubmed
pubmed-article:7805774pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:7805774pubmed:meshHeadingpubmed-meshheading:7805774-...lld:pubmed
pubmed-article:7805774pubmed:meshHeadingpubmed-meshheading:7805774-...lld:pubmed
pubmed-article:7805774pubmed:meshHeadingpubmed-meshheading:7805774-...lld:pubmed
pubmed-article:7805774pubmed:meshHeadingpubmed-meshheading:7805774-...lld:pubmed
pubmed-article:7805774pubmed:meshHeadingpubmed-meshheading:7805774-...lld:pubmed
pubmed-article:7805774pubmed:meshHeadingpubmed-meshheading:7805774-...lld:pubmed
pubmed-article:7805774pubmed:meshHeadingpubmed-meshheading:7805774-...lld:pubmed
pubmed-article:7805774pubmed:meshHeadingpubmed-meshheading:7805774-...lld:pubmed
pubmed-article:7805774pubmed:meshHeadingpubmed-meshheading:7805774-...lld:pubmed
pubmed-article:7805774pubmed:meshHeadingpubmed-meshheading:7805774-...lld:pubmed
pubmed-article:7805774pubmed:meshHeadingpubmed-meshheading:7805774-...lld:pubmed
pubmed-article:7805774pubmed:meshHeadingpubmed-meshheading:7805774-...lld:pubmed
pubmed-article:7805774pubmed:meshHeadingpubmed-meshheading:7805774-...lld:pubmed
pubmed-article:7805774pubmed:meshHeadingpubmed-meshheading:7805774-...lld:pubmed
pubmed-article:7805774pubmed:year1994lld:pubmed
pubmed-article:7805774pubmed:articleTitleBinding profile of the selective muscarinic receptor antagonist tripitramine.lld:pubmed
pubmed-article:7805774pubmed:affiliationInstitute of Pharmacology School of Medicine, University of Pisa, Italy.lld:pubmed
pubmed-article:7805774pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7805774pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7805774lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7805774lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7805774lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7805774lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7805774lld:pubmed